NewsAI-assisted
Marksans Pharma’s Goa Facility Receives EIR, Inspection Closed with VAI Classification
Marksans Pharma's Goa facility receives EIR from USFDA, inspection classified as VAI.
By Mrudula Kulkarni
Managing Editor - Pharma Now
Aug 21, 2024Updated Jun 26, 2025 · 2 min read
AI-assisted reporting
Reviewed by Mrudula Kulkarni, Managing Editor - Pharma Now
For its production site in Verna, Goa, Marksans Pharma said that the USFDA had issued an Establishment Inspection Report (EIR), which it has now successfully closed. According to USFDA findings, this facility's inspection categorisation is Voluntary Action Indicated (VAI).
TopicsNews
Written by
Mrudula Kulkarni
Managing Editor - Pharma Now
My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.
More from Pharma News
All stories →
News
CPHI Milan Pharma Awards 2026 Finalists Announced
Pharma Now Editorial Team · Sep 19, 2026
News
Pharming Group Gains FDA Approval for Leniolisib in Children Aged 4–11 with APDS
Vaibhavi M. · Sep 11, 2026
News
Lonza Builds Oregon Spray-Drying Facility To Expand SDD Capacity
Simantini Singh Deo · Sep 11, 2026
Discussion